Correction on the First Submission Date for Resubmission and Revision Applications for the Alzheimer’s Disease Drug Development Program (U01) (PA-10-205)

Notice Number: NOT-AG-10-006

Key Dates
Release Date: June 22, 2010

Issued by
National Institute on Aging (NIA), http://www.nia.nih.gov

Purpose

The purpose of this notice is to announce that no revision and resubmission applications will be accepted for August 4, 2010 for the Alzheimer’s Disease Drug Development Program (U01) (PA-10-205).  The first submission date for resubmission and revision applications will be November 5, 2010.

In addition, this notice clarifies Key Dates for this FOA.

The first letter of intent date will still be September 5, 2010 for new applications.

The first letter of intent date for resubmission or revision applications will be October 5, 2010.

The expiration date is still May 8, 2013.

All other aspects of the FOA remain unchanged.

Inquiries

For further information regarding this notice, please contact:

Suzana Petanceska, Ph.D.
Division of Neuroscience
National Institute on Aging
7201 Wisconsin Avenue, Suite 350, MSC 9205
Bethesda, MD 20892-9205
Telephone: (301) 496-9350
Fax: 301-496-1494
Email: petanceskas@nia.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.